Protecting communities to eliminate lymphatic filariasis in Kenya

Nairobi – In Kenya, regular mass drug administration is protecting a new generation from the effects of lymphatic filariasis, commonly known as elephantiasis ‒ a neglected tropical disease that affects the lymphatic system and can lead to the abnormal enlargement of body parts, causing pain, severe disability and social stigma.

WHO Hands Over US $2.3 Million in Ambulances, Medical Equipment and Supplies to Keny...

The World Health Organization (WHO) handed over critical medical supplies and equipment valued at over US$ 2.3 million to the Government of Kenya in a ceremony presided over by His Excellency President William Ruto at State House, Nairobi.


Dr. Mohamed Janabi, WHO Regional Director for Africa, presented the comprehensive package to President Ruto and the Government and people of Kenya, marking a significant investment in the country's health infrastructure and emergency response capacity.

Kenya certified for elimination of human African trypanosomiasis (sleeping sickness)

Nairobi I Brazzaville I Geneva ‒ The World Health Organization (WHO) has validated Kenya as having eliminated human African trypanosomiasis (HAT) or sleeping sickness as a public health problem, making it the tenth country to reach this important milestone. HAT is the second neglected tropical disease (NTD) to be eliminated in Kenya: the country was certified free of Guinea worm disease in 2018.

Enhancing reproductive health services through on-site mentorship in Kenya

At the busy Kitengela Hospital of Kajiado County in Southern Kenya, nurses Jackline Tabo and Grace Nyangweso bring healing in the quiet rooms where life’s most fragile moments happen. They are proud participants in WHO Kenya’s on-site mentorship, an initiative that’s designed to enhance the quality of sexual and reproductive health services at the point of care.